OBJECTIVE: To report the visual and refractive outcomes following monocular implantation of a supplementary (piggyback) Scharioth macula lens (SML) in previously pseudophakic eyes with age-related macular degeneration (AMD). METHODS AND ANALYSIS: Prospective European multicentre clinical trial. 50 eyes of 50 pseudophakic patients with either dry or previously treated and stable neovascular AMD for at least 6 months were included. The inclusion criteria were age over 55, corrected distance visual acuity (CDVA) of 0.4-0.1 (decimal), improvement of at least three lines of corrected near visual acuity (CNVA) when tested with a +6.0 dioptre (D) reading addition at 15 cm, compared with a +2.5 D reading addition at 40 cm using a standardised, self-illuminated Early Treatment Diabetic Retinopathy Study near vision chart. The SML intraocular lens (IOL) was implanted as an add-on/piggyback IOL in the ciliary sulcus, monocularly in the better seeing eye of each subject meeting the inclusion criteria. RESULTS: There were no intraoperative complications. One subject had the SML explanted in the postoperative period due to postoperative glare/halos. The mean CNVA improved from 0.23±0.12 (decimal) preoperatively to 0.57±0.33 at 1 year. The mean CDVA remained unchanged measuring 0.19±0.13 preoperatively and 0.19±0.09 at 1 year postoperatively. CONCLUSION: The SML appears to be safe and effective in improving the CNVA in patients with AMD. Data suggest that the CDVA remains unaffected following implantation. Further data are needed to assess the long-term safety and efficacy.

Aurelios Augenzentrum Recklinghausen Germany

Clinica Retina Bucharest Romania

Department of Ophthalmology Faculty Hospital of Hradec Králové HradecKrálové Czech Rebuplic

Department of Ophthalmology Semmelweis University Budapest Hungary

Department of Ophthalmology University Hospital Ayr UK

North View Eye Clinic Kiel Germany

Saint Joseph Clinic Lobbes Belgium

University of West of Scotland Ayr Scotland UK

ZRENIE Private Eye Center Sofia Bulgaria

BMJ Open Ophthalmol. 2019 Aug 9;4(1):e000322corr1. doi: 10.1136/bmjophth-2019-000322corr1. PubMed

Zobrazit více v PubMed

Bunce C, Xing W, Wormald R. Causes of blind and partial sight certifications in England and Wales: April 2007-March 2008. Eye 2010;24:1692–9. 10.1038/eye.2010.122 PubMed DOI

Wong WL, Su X, Li X, et al. . Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health 2014;2:e106–16. 10.1016/S2214-109X(13)70145-1 PubMed DOI

Pascolini D, Mariotti SP. Global estimates of visual impairment: 2010. Br J Ophthalmol 2012;96:614–8. 10.1136/bjophthalmol-2011-300539 PubMed DOI

Holz FG, Strauss EC, Schmitz-Valckenberg S, et al. . Geographic atrophy: clinical features and potential therapeutic approaches. Ophthalmology 2014;121:1079–91. 10.1016/j.ophtha.2013.11.023 PubMed DOI

Patel HR, Hariprasad SM, Eichenbaum D. Geographic atrophy: clinical impact and emerging treatments. Ophthalmic Surg Lasers Imaging Retina 2015;46:8–13. 10.3928/23258160-20150101-01 PubMed DOI

Age-Related Eye Disease Study 2 Research Group Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the age-related eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA 2013;309:2005–15. 10.1001/jama.2013.4997 PubMed DOI

Hooper P, Jutai JW, Strong G, et al. . Age-related macular degeneration and low-vision rehabilitation: a systematic review. Can J Ophthalmol 2008;43:180–7. 10.3129/i08-001 PubMed DOI

Ryan B, Culham L. Fragmented vision. Survey of low vision services in the UK. London: Royal National Institute for the Blind and Moorfields Eye Hospital NHS Trust, 1999.

Lizuka M, Gorfinkel J, Mandelcorn M, et al. . Modified cataract surgery with telescopic magnification for patients with age-related macular degeneration. Can J Ophthalmol 2007;42:854–9. PubMed

Gayton JL, Mackool RJ, Ernest PH, et al. . Implantation of multifocal intraocular lenses using a magnification strategy in cataractous eyes with age-related macular degeneration. J Cataract Refract Surg 2012;38:415–8. 10.1016/j.jcrs.2011.12.022 PubMed DOI

Alió JL, Mulet EM, José M, et al. . Intraocular telescopic lens evaluation in patients with age-related macular degeneration. J Cataract Refract Surg 2004;30:1177–89. 10.1016/j.jcrs.2003.10.038 PubMed DOI

Hudson HL, Lane SS, Heier JS, et al. . Implantable miniature telescope for the treatment of visual acuity loss resulting from end-stage age-related macular degeneration: 1-year results. Ophthalmology 2006;113:1987–2001. 10.1016/j.ophtha.2006.07.010 PubMed DOI

Orzalesi N, Pierrottet CO, Zenoni S, et al. . The IOL-Vip system: a double intraocular lens implant for visual rehabilitation of patients with macular disease. Ophthalmology 2007;114:860–5. 10.1016/j.ophtha.2007.01.005 PubMed DOI

Qureshi MA, Robbie SJ, Tabernero J, et al. . Injectable intraocular telescope: pilot study. J Cataract Refract Surg 2015;41:2125–35. 10.1016/j.jcrs.2015.03.021 PubMed DOI

Qureshi MA, Robbie SJ, Hengerer FH, et al. . Consecutive case series of 244 age-related macular degeneration patients undergoing implantation with an extended macular vision IOL. Eur J Ophthalmol 2018;28:198–203. 10.5301/ejo.5001052 PubMed DOI

Scharioth GB. New add-on intraocular lens for patients with age-related macular degeneration. Journal of Cataract & Refractive Surgery 2015;41:1559–63. 10.1016/j.jcrs.2015.07.018 PubMed DOI

Reiter N, Werner L, Guan J, et al. . Assessment of a new hydrophilic acrylic supplementary IOL for sulcus fixation in pseudophakic cadaver eyes. Eye 2017;31:802–9. 10.1038/eye.2016.310 PubMed DOI PMC

Schmier JK, Halpern MT, Covert D, et al. . Impact of visual impairment on use of caregiving by individuals with age-related macular degeneration. Retina 2006;26:1056–62. 10.1097/01.iae.0000254890.48272.5a PubMed DOI

Williams RA, et al. The psychosocial impact of macular degeneration. Arch Ophthalmol 1998;116:514–20. 10.1001/archopht.116.4.514 PubMed DOI

Brown MM, Brown GC, Stein JD, et al. . Age-related macular degeneration: economic burden and value-based medicine analysis. Can J Ophthalmol 2005;40:277–87. 10.1016/S0008-4182(05)80070-5 PubMed DOI

Decarlo DK, McGwin G, Searcey K, et al. . Use of prescribed optical devices in age-related macular degeneration. Optom Vis Sci 2012;89:1336–42. Jr 10.1097/OPX.0b013e3182678db5 PubMed DOI PMC

Choyce P. Intraocular lenses and implants. London: HK Lewis, 1964: 156–61.

Donn A, Koester CJ. An ocular telephoto system designed to improve vision in macular disease. Eye & Contact Lens: Science & Clinical Practice 1986;12:81–5. 10.1097/00140068-198604000-00007 PubMed DOI

Lipshitz I, Loewenstein A, Reingewirtz M, et al. . An intraocular telescopic lens for macular degeneration. Ophthalmic Surg Lasers 1977;28:513–7. PubMed

Kessel L, Erngaard D, Flesner P, et al. . Cataract surgery and age-related macular degeneration. an evidence-based update. Acta Ophthalmol 2015;93:593–600. 10.1111/aos.12665 PubMed DOI PMC

The intraocular implant and visual rehabilitation improve the quality of life of elderly patients with geographic atrophy secondary to age-related macular degeneration

Vision before and after scharioth macular lens implantation in patients with AMD: an electrophysiological study